As of 2025-07-08, the Fair Value of Acer Therapeutics Inc (ACER) is -7.31 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.90 USD, the upside of Acer Therapeutics Inc is -912.38%.
With the market price of 0.90 USD and our fair value calculation, Acer Therapeutics Inc (ACER) is not a good investment. Investing in ACER stocks now will result in a potential loss of 912.38%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -21.28 | -29.42 | -22.89 | -15.37 | -26.24 | -23.04 |
| YoY growth | -49.96% | -38.25% | 22.20% | 32.84% | -70.66% | -20.77% |
| Market Cap (mil) | 16.15 |
| P/E | |
| Forward P/E |
| EPS | -1.46 |
| Avg earnings growth rate | -20.77% |
| TTM earnings | -26.24 |